top of page
News & Announcements
Search


Biotome's PepLock surface conjugation technology has a home: peplock.au
PepLock now has a website of its own: peplock.au
Technology, applications, FAQ and more.
Oct 30


From antibody discovery to peptide diagnostics: watch Biotome’s webinars
How do you turn an interesting antibody response into an assay that works beyond the discovery platform? Two Biotome webinars, hosted by our long-standing partner PEPperPRINT and now available on YouTube, explore that journey from different starting points. CEO Dr Samuel Lundin shares the development of Helitope, our peptide-based anti-CagA IgG ELISA. CTO Luke Marshall takes a step further back, showing how our team approaches biomarker discovery when the target antigen is no
Oct 13


Biotome Launches Helitope RUO, Its First Commercial Peptide ELISA Diagnostic Kit
Biotome has launched its first commercial product, the Helitope® RUO Rapid Human anti-CagA Epitope IgG ELISA Kit.
Aug 3


Biotome Files International Patent Application for Peplock Biomolecule Anchoring Platform
Biotome has filed an international patent application elating to Peplock, its surface-binding peptide platform for stable biomolecule immobilisation on solid surfaces.
Jun 24


Biotome Welcomes Dr Maike Stentenbach
We’re delighted to welcome Dr Maike Stentenbach to Biotome as a Postdoctoral Scientist, joining the team in January 2026.
Feb 4
bottom of page
